CREATING A NEW VISION

LENTECHS, LLC is a privately held, clinical-stage ophthalmic medical device company, focused on developing a new generation of soft, suspended contact lenses. Headquartered in Columbus, Ohio, LENTECHS is backed by a network of investors who are truly committed to revolutionary innovation in contact lenses.

Vision solutions for life

In early 2022, LENTECHS will debut a new generation of soft, suspended, progressive contact lenses for millions of underserved people with presbyopia and presbyopia with astigmatism. Its breakthrough design leverages a unique, anatomically inspired design feature that allows for free, translational eye movement behind a rotationally stable lens.

Patented vision solutions

LENTECHS has patented its front-to-back lens innovations designed to deliver unique vision solutions in soft contact lenses.

Patents Granted

Contact lens comprising a superior lenticular aspect: USPTO #10,598,957

Contact lens comprising lenticular-like curve: USPTO #10,191,302

Patents Published
Contact lens comprising a lenticular in a superior portion of the contact lens: 20190391412

Collaboration minded. Innovation focused.

Founded with optometrist inventors Melissa Bailey, OD, PhD, and Joe Barr, OD, MS, FAAO, LENTECHS has successfully developed core technology licensed from The Ohio State University.

PRESIDENT AND CEO

Robin Sears

CHIEF MEDICAL OFFICER

Joe Barr, OD, MS, FAAO

VP OF RESEARCH AND DEVELOPMENT

Melissa Bailey, OD, PhD

CHIEF COMMERCIAL OFFICER

Paul Grimm

CHIEF FINANCIAL OFFICER

Brad Beasecker

Get in touch with LENTECHS

Question or comments? We want to hear from you.

The statements on this website have not been evaluated by the FDA, and the device is not currently available for purchase or use in the United States.